Sex as a prognostic factor in gastric cancer

European Journal of Cancer Part A

Volumn 32, Issue 8, 1996, Pages 1303-1309

  Maguire, A ^a   Porta, M ^a   Sanz Anquela, J M ^b   Ruano, I ^c   Malats, N ^a   Pinol J L ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Hospital General del Insalud Soria   (Spain)

^c Inst Recerca Epidemiologica i Clin   (Spain)

Author keywords

Carcinomas; Hospital; Prognosis; Sex; Stomach neoplasms; Survival; Tumour staging

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; SPAIN; STOMACH CANCER;

EID: 0030037198     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(96)00103-7     Document Type: Article

References (68)

1. Alexander HR, Kelsen DP, Tepper JE. Cancer of the stomach. In De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology, 4th edn. Philadelphia, JB Lippincott, 1993, 818-848.
2. Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995, 333, 32-41.
3. Miller BA. Stomach. In Miller BA, Ries LAG, Hankey BF, Kosary CL, Edwards BK, eds. Cancer Statistics Review: 1973-1989. NIH Pub. No. 92-2789. Bethesda, National Cancer Institute, 1992, xxiii, 1-9.
4. MacDonald WC, Rubin CE. Cancer, benign tumors, gastritis, and other gastric diseases. In Petersdorf RG, Adams RD, Braunwald E, Isselbacher KJ, Martin JB, Wilson JD, eds. Harrison's Principles of Internal Medicine, 10th edn. New York, McGraw-Hill, 1983, 1712-1720.
5. Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents, Volume VI. IARC Scientific Publications No. 120. New York, Oxford University Press, 1992.
6. Maehara Y, Watanabe A, Kakeji Y, et al. Prognosis for surgically treated gastric cancer patients is poorer for women than men in all patients under age 50. Br J Cancer 1992, 65, 417-420.
7. Davis GR. Neoplasms of the stomach. In Sleisinger MH, Fordham JS, eds. Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, 4th edn. Philadelphia, WB Saunders, 1989, 578-601.
8. Parrilla P, Garcia JA, Sánchez F, Ramirez P, Castellanos G. Valoración de factores pronósticos en el cáncer gástrico resecado (194 casos). Cir Esp 1990, 47, 164-172.
9. Swynnerton BF, Truelove SC. Carcinoma of the stomach. Br Med J 1952, 1, 287-292.
10. McNeer G, Lawrence W, Ashley MP, Pack GT. End results in the treatment of gastric cancer. Surgery 1958, 43, 879-896.
11. Faivre J, Milan C, Hillon P, Boutron MC, Michiels R, Kleeping C. Incidence, traitement et survie des cancers digestifs dans le département de la Côte-d'Or (1976-1980). Rev Fr Gastroenterol, Extrait du No. 194, 30 pages, Dec. 1983.
12. Wile AG, Hourani L, Schell MJ. The contributions of patient factors, physician delay, and tumour biology to the outcome of gastric cancer. Am Surg 1993, 59, 850-854.
13. Smolle-Juetter FM, Pinter H, Smolle J, et al. Surgical and non-surgical treatment of cancer of the oesophagus and the oesophagus and the oesophagogastric junction: results of 200 consecutive cases. Wein Klin Wochenchr 1992, 104, 563-569.
14. Moreno E, Figueroa JM, Hidalgo M, Escudero F, Santoyo J, Mansilla D. Tratamiento quirúrgico del cáncer gástrico. In Vilardell F, ed. Enfermedades digestivas. Madrid, CEA, 1990.
15. Ziliotto A, Kunzle JE, Alcides de Souza J, Colicchio-Filho O. Evolutive and prognostic aspects of gastric cancer. Analysis of 189 cases. Cancer 1987, 59, 811-817.
16. Lundegårdh G, Adami HO, Malker B. Gastric cancer survival in Sweden. Lack of improvement in 19 years. Ann Surg 1986, 204, 546-551.
17. Armstrong CP, Dent DM. Factors influencing prognosis in carcinoma of the stomach. Surg Gynecol Obstet 1986, 162, 343-348.
18. Rugge M, Sonego F, Panozzo M, et al. Pathology and ploidy in the prognosis of gastric cancer with no extranodal metastasis. Cancer 1994, 73, 1127-1133.
19. Jónasson L, Hallgrimsson J, Sigvaldason H, Ólafsdóttir G, Tulinius H. Gastric cancer in Iceland: a retrospective study of resected gastric specimens in a high-risk country during 30 years (1960-1989). Int J Cancer 1994, 57, 793-798.
20. Damhuis RAM, Tilanus HW. The influence of age on resection rates and postoperative mortality in 2773 patients with gastric cancer. Eur J Cancer 1995, 31A, 928-931.
21. Hoel DG, Davis DL, Miller AB, Sondik EJ, Swerdlow AJ. Trends in cancer mortality in 15 industrialized countries, 1969-1986. J Natl Cancer Inst 1992, 84, 313-320.
22. López-Abente Ortega G, Pollán Santamaría M, Ruiz Tovar M, Jiménez Rodriguez M, Vázquez Vizoso F. Cancer Mortality in Spain, 1952-1986. Effect of Age, Birth Cohort and Period of Death. Madrid, Centro Nacional de Epidemiología/Fareso, 1992.
23. Lundegårdh G, Lindgren A, Rohul A, et al. Intestinal and diffuse types of gastric cancer: secular trends in Sweden since 1951. Br J Cancer 1991, 64, 1182-1186.
24. Ikeda Y, Mori M, Kamakura T, Haraguchi Y, Saku M, Sugimachi K. Improvements in diagnosis have changed the incidence of histological types in advanced gastric cancer. Br J Cancer 1995, 72, 424-426.
25. Harrison JD, Jones JA, Ellis IO, Morris DL. Oestrogen receptor D5 antibody is an independent negative prognostic factor in gastric cancer. Br J Surg 1991, 78, 334-336.
26. Matsui M, Kojima O, Kawakami S, Uehara Y, Takahashi T. The prognosis of patients with gastric cancer possessing sex hormone receptors. Surg Today 1992, 22, 421-425.
27. Decarli A, La Vecchia C, Cislaghi C, Mezzanotte G, Marubini E. Descritive epidemiology of gastric cancer in Italy. Cancer 1986, 58, 2560-2569.
28. González CA, Sanz JM, Marcos G, et al. Dietary factors and stomach cancer in Spain: a multi-centre case-control study. Int J Cancer 1991, 49, 513-519.
29. Gonzalez CA, Sanz M, Marcos G, et al. Occupation and gastric cancer in Spain. Scand J Work Environ Health 1991, 17, 240-247.
30. Ramón JM, Serra L. Epidemiologia descriptiva del cáncer gástrico en Cataluña (1983-1986). Gac Sanit 1990, 4, 76-77.
31. Ramón JM, Serra L, Cerdó C, Oromí J. Dietary factors and gastric cancer risk. Cancer 1993, 71, 1731-1735.
32. Errezola M, Lopez-Abente G, Escolar A. Geographical patterns of cancer mortality in Spain. Recent Results Cancer Res 1989, 114, 154-162.
33. Vioque J, Merino C, Porta M. Stomach cancer mortality in Spain: an ecological analysis of diet, altitude, latitude, and income. J Epidemiol Community Health 1995, 49, 441-442.
34. Planas J, Gallén M, Malats N, Porta M, Guasch I, Cardona T. Registro de tumores del Hospital del Mar (Barcelona). Análisis descriptivo 1978-1986. Rev Clín Esp 1988, 183, 175-179.
35. Porta M, Gallén M, Malats N, Planas J. Influence of "diagnostic delay" upon cancer survival: an analysis of five tumour sites. J Epidemiol Community Health 1991, 45, 225-230.
36. Maguire A, Porta M, Malats N, Gallén M, Piñol JL, Fernandez E for the ISDS II Project Investigators. Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. Eur J Cancer 1994, 30A, 785-792.
37. Spiessl B, Beahrs OH, Hermanek P, et al. TNM Atlas. Illustrated Guide to the TNM/pTNM-classification of Malignant Tumours, 3rd edn. Berlin, Springer, 1989.
38. Hermanek P, Sobin LH, eds. UICC TNM Classification of Malignant Tumours, 4th edn, 2nd rev. Berlin, Springer, 1992.
39. ICD-O: International Classification of Diseases for Oncology, 2nd edn. Geneva, World Health Organization, 1990.
40. Järvi O, Nevalainen T, Ekfors T, Kulatunga A. The classification and histogenesis of gastric cancer. Proc XI Int Cancer Congr (Florence, 1974). Excerpta Medico International Congress Series, No. 354, Vol. 6. Tumors of Specific Sites. Amsterdam, Excerpta Medica, 1975, 228-234.
41. Järvi O, Nevalainen T, Ekfors T, Kulatunga A. The classification and histogenesis of gastric cancer. Proc XI Int Cancer Congr (Florence, 1974). Excerpta Medico International Congress Series, No. 354, Vol. 6. Tumors of Specific Sites. Amsterdam, Excerpta Medica, 1975, 228-234.
42. Sanz-Anquela JM, Ruiz Liso JM, Rodriguez Manzanilla L, et al. Importancia de la clasificación de Laurén del cáncer gástrico. Revisión de una serie de 295 casos. Patologia 1989, 22, 156-161.
43. Sanz-Anquela JM, Agudo A, García-Julián G, et al. Concordancia en el diagnóstico histológico de la clasificación de Laurén del cáncer gástrico. Med Clin (Barc) 1992, 98, 572-575.
44. Armitage P, Berry G. Statistical Methods in Medical Research, 2nd edn. Oxford, Blackwell, 1987.
45. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, John Wiley, 1980.
46. Akoh JA, Macintyre IMC. Improving survival in gastric cancer: review of 5-year survival rates in English language publications from 1970. Br J Surg 1992, 79, 293-299.
47. Filipe MI, Rosa J, Sandey A, Imrie PR, Ormerod MG, Morris RW. Is DNA ploidy and proliferative activity of prognostic value in advanced gastric carcinoma? Human Pathol 1991, 22, 373-378.
48. Wanebo HJ, Kennedy BJ, Chmiel J, Steele G Jr, Winchester D, Osteen R. Cancer of the stomach. A patient care study by the American College of Surgeons. Ann Surg 1993, 218, 583-592.
49. Salvon-Harman JC, Cady B, Nikulasson S, Khettry U, Stone MD, Lavin P. Shifting proportions of gastric adenocarcinomas. Arch Surg 1994, 129, 381-388.
50. Curtis RE, Kennedy BJ, Myers MH, Hankley BF. Evaluation of AJC stomach cancer staging using the SEER population. Semin Oncol 1985, 12, 21-31.
51. Bako G, Ferenczi L, Hanson J, Hill GH, Dewar R. Factors influencing the survival of patients with cancer of the stomach. Clin Invest Med 1985, 8, 22-28.
52. Vassilakos P, Raymond L, Obradovic M. Cancer à Genève: Incidence, mortalité, survie (1970-1986). Geneva, Registre Genevois des Tumeurs, 1988.
53. Hallissey MT, Dunn JA, Ward LC, Allum WH, for the British Stomach Cancer Group. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet 1994, 343, 1309-1312.
54. Monson JR, Donohue JH, McIlrath DC, Farnell MB, Ilstrup DM. Total gastrectomy for advanced cancer. A worthwhile palliative procedure. Cancer 1991, 68, 1863-1868.
55. Porta M, Malats N, Piñol JL, Rifà J, Andreu M, Real FX, for the PANKRAS I Project Investigators. Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. J Clin Epidemiol 1994, 47, 1069-1079.
56. Fernandez E, La Vecchia C, Porta M, Negri E, Lucchini F, Levi F. Trends in pancreatic cancer mortality in Europe, 1955-1989. Int J Cancer 1994, 57, 786-792.
57. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985, 312, 1604-1608.
58. Bunt AMG, Hermans J, Smit VTHBM, van de Velde CJH, Fleuren GJ, Bruijn JA. Surgical/pathological-stage migration confounds comparisons of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995, 13, 19-25.
59. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J, eds. Survival of Cancer Patients in Europe. The EURO-CARE study. IARC Scientific Publications, No. 132. Lyon, International Agency for Research on Cancer, 1995, 167-179, 447-463.
60. Steinmetz KA, Potter JD. Vegetables, fruit and cancer. II. Mechanisms. Cancer Causes Control 1991, 2, 427-442.
61. Kato I, Tominaga S, Ikari A. The role of socioeconomic factors in the survival of patients with gastrointestinal cancers. Jpn J Clin Oncol 1992, 22, 270-277.
62. Kogevinas M, Porta M. Socioeconomic differences in cancer survival: a review of the evidence. In Boffetta P, Kogevinas M, Pearce N, Susser M, eds. Socioeconomic Factors and Cancer. IARC Scientific Publications. Lyon, International Agency for Research on Cancer, 1996 (in press).
63. Nomura A. Stomach. In Schottenfeld D, Fraumeni JF, eds. Cancer Epidemiology and Prevention. Philadelphia, WB Saunders, 1982, 624-637.
64. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process. Cancer Res 1992, 52, 6735-6740.
65. Steinmetz KA, Potter JD. Vegetables, fruit and cancer. I. Epidemiology. Cancer Causes Control 1991, 2, 325-357.
66. Maetani S, Tobe T, Hirakawa A, Kashiwara S, Kuramoto S. Parametric survival analysis of gastric cancer patients. Cancer 1980, 46, 2709-2716.
67. Sue-Ling HM, Johnston D, Martin IG, Dixon MF, Lansdown MRJ, McMahon MJ, Axon ATR. Gastric cancer: a curable disease in Britain. Br Med J 1993, 307, 591-596.
68. Thompson GB, van Heerden JA, Sarr MG. Adenocarcinoma of the stomach: are we making progress? Lancet 1993, 342, 713-718.